AMEDISYS INC Quarterly Costs and Expenses in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Amedisys Inc quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q4 2024.
  • Amedisys Inc Costs and Expenses for the quarter ending December 31, 2024 was $618M, a 15.1% increase year-over-year.
  • Amedisys Inc Costs and Expenses for the twelve months ending December 31, 2024 was $2.25B, a 8.36% increase year-over-year.
  • Amedisys Inc annual Costs and Expenses for 2024 was $2.25B, a 8.36% increase from 2023.
  • Amedisys Inc annual Costs and Expenses for 2023 was $2.08B, a 1.84% increase from 2022.
  • Amedisys Inc annual Costs and Expenses for 2022 was $2.04B, a 3.39% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $2.25B $618M +$80.9M +15.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $2.17B $557M +$43.3M +8.43% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $2.13B $539M +$23.8M +4.62% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $2.11B $540M +$25.8M +5.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $2.08B $537M +$21M +4.06% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $2.06B $514M -$5.03M -0.97% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.06B $515M +$4.92M +0.97% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $2.06B $514M +$16.7M +3.36% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $2.04B $516M +$4.67M +0.91% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $2.04B $519M +$22.3M +4.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-25
Q2 2022 $2.02B $510M +$19.6M +4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $2B $497M +$20.3M +4.26% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.98B $511M +$15.8M +3.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $1.96B $497M +$11.1M +2.29% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $1.95B $491M +$32.7M +7.15% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $1.92B $477M +$29.2M +6.52% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $1.89B $495M +$36.2M +7.89% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $1.85B $486M +$37.8M +8.44% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $1.81B $458M +$9.67M +2.16% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.8B $448M +$24.8M +5.86% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $1.78B $459M +$61.2M +15.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $1.72B $448M +$70.3M +18.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $1.65B $448M +$79.5M +21.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $1.57B $423M +$59.8M +16.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.51B $398M +$29.7M +8.08% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $1.48B $377M +$27.1M +7.74% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $1.45B $369M -$5.93M -1.58% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $1.46B $363M +$23.8M +7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $1.43B $368M +$33.7M +10.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-19
Q3 2017 $1.4B $350M +$3.1M +0.89% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $1.4B $375M +$32.3M +9.44% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $1.36B $339M +$1.74M +0.52% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $1.36B $335M +$12.9M +4% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $1.35B $347M +$37.5M +12.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $1.31B $342M +$43.8M +14.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $1.27B $338M -$21.9M -6.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $1.29B $322M +$36M +12.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $1.25B $310M +$25.7M +9.05% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $1.23B $299M +$6.18M +2.11% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $1.22B $360M +$41.4M +13% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $1.18B $286M -$28.1M -8.97% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $1.21B $284M -$171M -37.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $1.38B $292M -$19.3M -6.18% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-29
Q1 2014 $1.4B $318M -$4.92M -1.52% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 $1.4B $314M -$181M -36.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 $1.59B $456M +$107M +30.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $1.48B $312M -$36M -10.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-30
Q1 2013 $1.51B $323M -$35.1M -9.81% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $1.55B $495M +$190M +62.2% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-04
Q3 2012 $1.36B $349M -$576M -62.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $1.94B $348M +$19.3M +5.89% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 $1.92B $358M +$29.2M +8.87% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-30
Q4 2011 $1.89B $305M +$37K +0.01% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 $1.89B $925M +$558M +152% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $1.33B $328M -$37.9M -10.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $1.37B $329M -$21.9M -6.24% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q4 2010 $1.39B $305M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-12
Q3 2010 $368M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-01
Q2 2010 $366M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02
Q1 2010 $351M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.